MicroRNA-181 targets Yin Yang 1 expression and inhibits cervical cancer progression
Authors:
- 10 February 2015
- journal article
- Published by Spandidos Publications in Molecular Medicine Reports
- Vol. 11 (6) , 4541-4546
Abstract
Dysregulated expression of microRNAs (miRNAs) has been observed in numerous types of human cancer, including cervical cancer (CC). The present study aimed to elucidate the expression and roles of miR‑181 in cervical cancer tissues and cells. HeLa cells with a stable overexpression of miR‑181 were generated and injected subcutaneously into the front legs of nude mice. Functional assays revealed a reduced rate of proliferation and an enhanced rate of apoptosis following transfection of CC cells with miR‑181 mimics. In addition, miR‑181 also suppressed tumor growth in the nude mice. At the molecular level, it was found that Yin Yang 1, an oncogene in several types of human cancer, was negatively regulated by miR‑181. Therefore, the findings of the present study suggest that exogenous overexpression of miR‑181 may be a potential approach for the treatment of CC in the future.Keywords
This publication has 22 references indexed in Scilit:
- The Role of Inflammation in Cervical Cancer2014
- Upregulation of miR-96 Enhances Cellular Proliferation of Prostate Cancer Cells through FOXO1PLOS ONE, 2013
- Adult-specific functions of animal microRNAsNature Reviews Genetics, 2013
- Diversifying microRNA sequence and functionNature Reviews Molecular Cell Biology, 2013
- HDAC6 promotes hepatocellular carcinoma progression by inhibiting P53 transcriptional activityFEBS Letters, 2013
- Upregulation of MircoRNA-370 Induces Proliferation in Human Prostate Cancer Cells by Downregulating the Transcription Factor FOXO1PLOS ONE, 2012
- Cervical cancer—should we abandon cytology for screening?Nature Reviews Clinical Oncology, 2012
- MicroRNA‐223 regulates FOXO1 expression and cell proliferationFEBS Letters, 2012
- The burden of cervical cancer in China: Synthesis of the evidenceInternational Journal of Cancer, 2011
- Antigen‐specific immunotherapy of cervical and ovarian cancerImmunological Reviews, 2008